English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 852119 Online Users : 1360
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
癌症研究所
陳立宗
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
癌症研究所
>
陳立宗
>
期刊論文
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
圖書
[
1
/1]
會議論文/會議摘要
[
115
/179]
Collection Statistics
近3年內發表的文件:58(17.58%)
含全文筆數:327(99.09%)
文件下載次數統計
下載大於0次:327(100.00%)
下載大於100次:311(95.11%)
檔案下載總次數:137594(77.78%)
最後更新時間: 2024-11-28 12:19
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Pan-Asian adapted ESMO clinical pra...
Nivolumab plus chemotherapy in pati...
Survival of advanced/recurrent gast...
Topiramate suppresses peri-infarct ...
A phase 1 study of biweekly nab-pac...
Plain language summary of the FOENI...
Outcomes of post-immunotherapy dura...
Durvalumab or placebo plus gemcitab...
Impact of previous S-1 treatment on...
Chromatin remodeling-related PRDM1 ...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 26-50 of 330. (14 Page(s) Totally)
<<
<
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2023-02
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan
ESMO Open. 2023 Feb;8(1):Article number 100746.
2023-01-21
Adjuvant therapy in biliary tract cancers: Oral fluoropyrimidine as a beginning
Lancet. 2023 Jan 21-27;401(10372):170-171.
2023-01-20
ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance
iScience. 2023 Jan 20;26(1):Article number 105881.
2023-01-19
Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma
New England Journal of Medicine. 2023 Jan 19;388(3):228-239.
2023-01-06
Visible CCD camera-guided photoacoustic imaging system for precise navigation during functional rat brain imaging
Biosensors. 2023 Jan 6;13(1):Article number 107.
2023-01
TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIdelta/AKT pathway
Journal of Advanced Research. 2023 Jan;43:45-57.
2022-12-28
Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan
Scientific Reports. 2022 Dec 28;12:Article number 22492.
2022-12-15
Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway
Life Sciences. 2022 Dec 15;311(Part A):Article number 121135.
2022-11-06
PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation
Journal of Biomedical Science. 2022 Nov 06;29:Article number 92.
2022-11-01
Revisiting the cerebral hemodynamics of awake, freely moving rats with repeated ketamine self-administration using a miniature photoacoustic imaging system
Neurophotonics. 2022 Nov 01;9(4):Article number 045003.
2022-10
Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study
Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257.
2022-10
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma
Hepatology International. 2022 Oct;16(5):1137-1149.
2022-09-21
Clustering of chromatin remodeling enzymes predicts prognosis and clinical benefit of therapeutic strategy in pancreatic cancer
International Journal of Medical Sciences. 2022 Sep 21;19(10):1615-1627.
2022-09-15
Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
American Journal of Cancer Research. 2022 Sep 15;12(9):4267-4278.
2022-09
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study
European Journal of Cancer. 2022 Sep;173:123-132.
2022-09
Systemic treatment of advanced unresectable hepatocellular carcinoma after first-line therapy: Expert recommendations from Hong Kong, Singapore, and Taiwan
Liver Cancer. 2022 Sep;11(5):426-439.
2022-06-22
Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study
Frontiers in Oncology. 2022 Jun 22;12:Article number 800842.
2022-06-02
Trial Designs for integrating novel therapeutics into the management of intermediate-stage hepatocellular carcinoma
Journal of Hepatocellular Carcinoma. 2022 Jun 2;9:517-536.
2022-06
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin
Journal of Hepato-Biliary-Pancreatic Sciences. 2022 Jun;54(5):607-612.
2022-05-15
Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience
American Journal of Cancer Research. 2022 May 15;12(5):2189-2202.
2022-05
Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness
Cancer Science. 2022 May;113(5):1601-1612.
2022-04-18
The trinity: Interplay among cancer cells, fibroblasts, and immune cells in pancreatic cancer and implication of CD8(+) T cell-orientated therapy
Biomedicines. 2022 Apr 18;10(4):Article number 926.
2022-04-15
The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan
American Journal of Cancer Research. 2022 Apr 15;12(4):1884-1898.
2022-04-11
Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment
Journal of Experimental and Clinical Cancer Research. 2022 Apr 11;41:Article number 137.
2022-04
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
British Journal of Cancer. 2022 Apr;126(7):1018-1026.
Showing items 26-50 of 330. (14 Page(s) Totally)
<<
<
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback